G2G-26253-19209
3 vaccinations
6 coded responses
16 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 152 / PA
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
TYU-10208-85942
Child or adolescent in my care · Male · 2022-06-26
Timeline
-
2021-01-21
Dose 1 — Pfizer-BioNTech
-
2021-02-11
Registered in v-safe
-
2021-02-11
Dose 2 — Pfizer-BioNTech
- 2021-02-11
-
2021-02-12
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Dizziness, intermittentlyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-13
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessFree text: Little appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-14
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-25
-
2021-03-04
Survey response — day 21, dose 2MedDRA: Diarrhoea, Headache, Oropharyngeal pain — Feeling: GoodFree text: Sore throat today, slight headache, loose stools last 2 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-05-13
-
2021-08-12
Survey response — 6 months, dose 2MedDRA: Conjunctivitis, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Currently have an upper respiratory infection and mild conjunctivitisMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-12
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-19
-
2021-12-04
Dose 3 — Pfizer-BioNTech
-
2022-02-11
Survey response — 12 months, dose 2MedDRA: Chest discomfort, Chest pain, Cough, Dyspnoea, Fatigue, Migraine, Myalgia, Nasal congestion, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid positive home test on 1/7/22 with sxs of nasal congestion, cough, fatigue, pressure/pain in chest, shortness of breath, muscle aches, migraines. Sxs over the course of ~1moMedDRA releases: 2024-11 · check-in free text available
-
2022-12-04
Survey response — 12 months, dose 3MedDRA: Headache, Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Had a cold this past week with runny nose, headache; tested negative for covid.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-11 | Pfizer-BioNTech | |
| 3 | 2021-12-04 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness, intermittently
Systemic reaction (other): Little appetite
Release 5 — day 21, dose 2
Symptoms: Sore throat today, slight headache, loose stools last 2 days
Release 9 — 6 months, dose 2
Symptoms: Currently have an upper respiratory infection and mild conjunctivitis
Release 11 — 12 months, dose 2
Symptoms: Covid positive home test on 1/7/22 with sxs of nasal congestion, cough, fatigue, pressure/pain in chest, shortness of breath, muscle aches, migraines. Sxs over the course of ~1mo
Release 12 — 12 months, dose 3
Symptoms: Had a cold this past week with runny nose, headache; tested negative for covid.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest discomfort | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Conjunctivitis | ✓ | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Upper respiratory tract infection | ✓ | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release